The lawsuits accuse drug makers of overstating the benefits of opioids while downplaying the risks. Photograph: Eric Baradat/AFP via Getty

Four large drug companies reached a last-minute $260 million (€233 million) legal settlement over their role in the US opioid addiction epidemic, aver(...)

The first landmark US federal opioid trial is set to begin Monday after furious, last-minute settlement talks  faltered. Photograph: Ty Wright

Drugmaker Teva Pharmaceuticals and three distributors of opioid painkillers reached a settlement with two US counties over their alleged role in the o(...)

UK prime minister Boris Johnson told Conservative MPs that his government is nearing an accord with the EU.

Irish shares and the wider European equities market dipped on Wednesday as investors adopted a more cautious stance ahead of a bulletin on the much so(...)

US treasury secretary Steven Mnuchin arriving at a hotel after meeting with Chinese officials in Beijing on Thursday. Photograph: AP Photo/Andy Wong

Lingering concerns about the outcome of US-China trade talks and the potential for rising interest rates in the US troubled global investors on Thursd(...)

The Dow has topped 22,000 points for the first time, bolstered by a 6%  gain in Apple. Photograph: iStock

Ireland’s benchmark index closed lower by 0.87 per cent on Wednesday, a day when the Dow Jones industrial average achieved another milestone by pushin(...)

Medtronic worker: Cardinal Health is acquiring the medical supplies business of healthcare giant Medtronic.   Photograph: Munshi Ahmed/Bloomberg

The news that Cardinal Health is acquiring the medical supplies business of healthcare giant Medtronic was fairly well flagged within the industry. B(...)

Cardinal Health is acquiring Medtronic’s patient care, deep vein thrombosis and nutritional insufficiency units. (Photograph: Munshi Ahmed/Bloomberg)

Healthcare giant Medtronic has sold it medical supplies business to rival Cardinal Health. Medtronic’s Tullamore plant will be one of 17 company faci(...)

Last quarter Johnson & Johnson was the first of many drugmakers to report lower-than-expected guidance or sales declines due to the US currency’s gain

Johnson & Johnson, the world’s biggest maker of healthcare products, reported quarterly earnings that topped analysts’ estimates as new cancer and(...)